The mission of the ENNCF Proteomics Core is to provide protein analytical services by cutting-edge mass spectrometry (MS). Our main technology platform is liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) for highly sensitive protein identification, post-translational site mapping, and protein quantification. The Core has become an important technological resource for NINDS funded investigators at Emory University and is the only proteomics core on campus. Over the past 5 years the Core has supported over 21 NINDS funded investigators across Emory University representing a diverse number of departments including Neurology, Cell Biology, Biochemistry, Pharmacology, Genetics, Physiology, and Pathology. The primary objectives of the ENNCF Proteomics core are to provide: (1) access to state-of-the-art mass spectrometry that include four mass spectrometers a) LTQ-Orbitrap mass spectrometer, b) Quadrupole- Orbitrap Hybrid Mass Spectrometer, c) Orbitrap Fusion Tribrid Mass Spectrometer and, d) Orbitrap Fusion Tribrid Mass Spectrometer with Electron Transfer Dissociation (ETD), quantitative proteomics software and emerging peptide/protein enrichment technologies, (2) expertise and guidance on quantitative proteomics approaches, post-translational modifications, data analysis and services through direct consultation with core director and personnel, and (3) an outstanding research environment that provides infrastructure, education and resources to both build new and foster current collaborations between ENNCF investigators and other cores. Successful completion of the objectives implemented by the proteomics core will stimulate multidisciplinary research and innovation in basic and translational neuroscience across Emory University. Together these aims have a proven track record of serving the Emory neuroscience community to increase the quality of proteomics data through optimization of experimental design, prompt, efficient and sensitive primary data collection, proper interpretation of output, and cost savings. These benefits accrue overwhelmingly to NINDS funded investigators through support of the Core from ENNCF, the Emory School of Medicine, and subsidies made possible by this P30.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
5P30NS055077-07
Application #
9116314
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
7
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Srikanth, Priya; Lagomarsino, Valentina N; Pearse 2nd, Richard V et al. (2018) Convergence of independent DISC1 mutations on impaired neurite growth via decreased UNC5D expression. Transl Psychiatry 8:245
Abreha, Measho H; Dammer, Eric B; Ping, Lingyan et al. (2018) Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics 18:e1800108
Gigante, Eduardo D; Long, Alyssa Bushey; Ben-Ami, Johanna et al. (2018) Hypomorphic Smo mutant with inefficient ciliary enrichment disrupts the highest level of vertebrate Hedgehog response. Dev Biol 437:152-162
Zhao, Kai; Shen, Chengyong; Li, Lei et al. (2018) Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4. J Neurosci 38:8860-8873
Gerber, Kyle J; Squires, Katherine E; Hepler, John R (2018) 14-3-3? binds regulator of G protein signaling 14 (RGS14) at distinct sites to inhibit the RGS14:G?i-AlF4- signaling complex and RGS14 nuclear localization. J Biol Chem 293:14616-14631
Squires, Katherine E; Gerber, Kyle J; Pare, Jean-Francois et al. (2018) Regulator of G protein signaling 14 (RGS14) is expressed pre- and postsynaptically in neurons of hippocampus, basal ganglia, and amygdala of monkey and human brain. Brain Struct Funct 223:233-253
Yang, Su; Li, Shihua; Li, Xiao-Jiang (2018) Shortening the Half-Life of Cas9 Maintains Its Gene Editing Ability and Reduces Neuronal Toxicity. Cell Rep 25:2653-2659.e3
Schiavon, Cara R; Griffin, Maxwell E; Pirozzi, Marinella et al. (2018) Compositional complexity of rods and rings. Mol Biol Cell 29:2303-2316
Rangaraju, Srikant; Raza, Syed Ali; Li, Noel Xiang'An et al. (2018) Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes-Activation and Age-Related Effects. Front Immunol 9:405

Showing the most recent 10 out of 256 publications